L39 Capital
  • Home
  • AI Biotech Fund
  • About
    • Performance
    • Team
  • Our Approach
    • Our Philosophy
  • Investment Process
  • Our Investments
  • Invest Now
  • Contact

The AI Biotech Fund is now live:
visit aibiotechfund.com


L39 CAPITAL

Patient Capital, Active Participation
No Management Fees
With no management fees, we don't get paid unless you do, aligning our interests
We're in it together
Being major unit holders of the fund, we understand the importance of capital preservation ​
Critical Thinkers​
​We employ independent and contrarian thinking, challenging the status quo 
Who We Are
L39 Capital is a private managed fund focused on investing in small-cap companies, both listed and unlisted. The Fund targets long-term returns of over 20% p.a.*, which are generally less correlated to the broader market. Our motto is 'Patient Capital, Active Participation'  and this drives our investment process, from origination to exit. 

Our strength lies in the Australian small-cap sector, which is largely overlooked by many investors either due to institutional mandates or because it is perceived to be too risky. This lack of attention leads to a lack of information and ultimately misunderstanding, which we seek to exploit. 

Our main strategy is to seek high quality businesses that are run by competent people and are at prices that offer an attractive return on investment. We achieve this by taking the time to get to know management, their business and thinking. 

As the Investment Manager we follow a core set of beliefs which include having an investment philosophy & process, being an active manager but patient investors, being critical thinkers, and having strong alignment with our investors.

The Manager also provides Corporate Advisory services, leveraging its local and overseas connections to assist companies with a range of needs, from facilitating refinancing to offering strategic support.

Please explore our site, get to know us and  our approach and then feel free to get in touch if you would like to meet us. 
​
*Target rate of return only. Rate of return may not be achieved and may be negative. Past performance is not a reliable indicator of future performance
Our Performance
Picture

Performance
See our results
Investment Process
Explore our investment process
Our Philosophy ​
Discover our philosophy​
Team
Meet the team
T:  +61 415 634 468
E:  [email protected]
Level 1, Suit 7
321 Chapel Street
Prahran, Victoria, 3181
​Australia
© COPYRIGHT 2022 L39 Capital | ABN 94 614 364 117
L39 Capital Pty Ltd (L39) ABN 94 614 364 117 is a Corporate Authorised Representative (CAR #1250323) of Primary Securities Ltd (Primary) ABN 96 089 812 635 AFSL 224107. Primary is the trustee of the L39 Capital fund. L39 is authorised to provide general advice only to wholesale investors. This website is for general informational purposed only and no person(s) circumstances, objectives or needs have been taken into account when preparing this information.
  • Home
  • AI Biotech Fund
  • About
    • Performance
    • Team
  • Our Approach
    • Our Philosophy
  • Investment Process
  • Our Investments
  • Invest Now
  • Contact